Tag: Sequencing
Fortis and Agilus expand rapid genomic testing capabilities with launch of...
The Genexus platform enables Next-Generation Sequencing (NGS) with an unparalleled turnaround time - delivering crucial results such as Liquid Biopsy in 24 hours, Myeloid NGS in 72 hours, and MRD testing within 5 days
AIIMS Jammu collaborates with 4baseCare to launch Centre for Advanced Genomics...
This powerful capability enables clinicians to design highly personalized, targeted treatment plans tailored to each patient’s unique molecular profile
MedGenome partners with Darshan GIVA Foundation to revolutionize TB diagnosis using...
The partnership aims at an access intervention pilot for offering Whole Genome Sequencing (WGS) testing free of cost to pre diagnosed Drug-resistant TB (DRTB) patients
BioVoice eMagazine March & April 2024 | Issue 2 | Volume...
Cover story tracks the journey of MedGenome, the India’s leading genomics solutions company. Startup Special features MyHealthcare App; Expert Insights by Dr Kausik Maiti, Parexel India; Ankit Kumar, Skye Air; Dr Sat Kumar Tomer, Satyukt Analytics; and Ritwik Bahuguna, Farlense Group
Next-generation sequencers market will reach $5.1 billion in 2033, forecasts GlobalData
With decreased test fees, GlobalData anticipates that the demand for routine diagnostic procedures, including cancer panel testing and non-invasive prenatal testing, will grow
Next-generation sequencing breakthroughs drive personalized medicine into mainstream healthcare, says GlobalData
This evolution holds the promise of tailoring medical interventions to individual genetic profiles for more effective and targeted healthcare outcomes, according to GlobalData, a leading data and analytics company
Zydus & Guardant Health to jointly promote next-gen genomic tests for...
Precision oncology next-generation sequencing tests help oncologists start patients on the best targeted treatment option based on their tumour genomic profile and monitor response to that treatment
BioVoice eMagazine July 2023 | Issue 7 | Volume 4
This edition showcases the top 10 biotechnologies to watch out for in 2023. Insightful interviews of Piyush Sohani, Managing Director, Sistema.bio India and Dr Rachna Dave, CEO & Founder of MicroGO.
C2i Genomics & Karkinos Healthcare partner to bring AI-powered cancer detection...
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
FIND & CSIR-IGIB partner to strengthen genomic surveillance of SARS-CoV-2 in...
The partnership will serve to optimize and scale the capacity needed to identify SARS-CoV-2 variants of concern (VOC) and variants of interest (VOI)